<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="219033">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00232895</url>
  </required_header>
  <id_info>
    <org_study_id>02AR36</org_study_id>
    <nct_id>NCT00232895</nct_id>
  </id_info>
  <brief_title>Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Child Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Child Health</source>
  <brief_summary>
    <textblock>
      Randomised controlled trial of pain of injection of lipuro in children age 1-7 versus the
      pain of injection of the standard formulation
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date>August 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain scores on induction of anaesthesia with propofol</measure>
  </primary_outcome>
  <condition>ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lipuro propofol</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard formulation propofol</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1 or 2 requiring intravenous general anaesthetic

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Thomas, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Great Ormond Street Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Great Ormond Street Hospital</name>
      <address>
        <city>London</city>
        <zip>WC1N 1EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <lastchanged_date>March 27, 2007</lastchanged_date>
  <firstreceived_date>October 4, 2005</firstreceived_date>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
